Effects of Intensive Long-Term Vasodilation in Hypertensive Patients With Microvascular Angina Pectoris
NCT00424801 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2009-05-06
Summary
The purpose of this study is to determine if long-term vasodilatory treatment is more effective than the standard treatment in hypertensive patients with microvascular angina pectoris
Conditions
- Microvascular Angina
- Hypertension
Interventions
- DRUG
-
Lercanidipine
Individual titration, max. dose 20 mg OD for 8 months
- DRUG
-
Valsartan
Individual titration, max. dose 160 mg OD for 8 months
- DRUG
-
Nicorandil
Individual titration, max. dose 20 mg BD for 8 months
- DRUG
-
Doxazosin
Individual titration, max. dose 4 mg OD for 8 months
- DRUG
-
Moxonidin
Possible add-on therapy in case target blood pressure can not be reached with a combination of the other drugs in the Vasodilatory arm. Individual titration, max. dose 0,2 mg OD for 8 months
- DRUG
-
Pindolol
Possible add-on therapy in case target blood pressure can not be reached with a combination of the other drugs in the Vasodilatory arm. Individual titration, max. dose 10 mg OD for 8 months
- DRUG
-
Amiloride, hydrochlorothiazide
Possible add-on therapy in case target blood pressure can not be reached with a combination of the other drugs in the Vasodilatory arm. Individual titration, max. dose 1 tbl. OD for 8 months
Sponsors & Collaborators
-
Danish Cardiovascular Research Academy
collaborator UNKNOWN -
Danish Heart Foundation
collaborator OTHER - collaborator INDUSTRY
-
University of Aarhus
lead OTHER
Principal Investigators
-
Michael N Præstholm, MD · University of Aarhus
-
Kent L Christensen, MD, DrMSc · Aarhus Hospital, medical-cardiologic dept. A
-
Won Yong Kim, MD, DrMSc · Skejby Hospital, cardiologic dept. B
-
Hans Erik Bøtker, MD, DrMSc · Skejby Hospital, cardiologic dept. B
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-01-31
- Primary Completion
- 2008-12-31
- Completion
- 2008-12-31
Countries
- Denmark
Study Locations
More Related Trials
-
Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome
NCT00429364 ·Status: COMPLETED ·Phase: PHASE3
-
Estimation of the Long Term Effectiveness of Routine Use of Cardiac Shock Wave Therapy
NCT01631409 ·Status: WITHDRAWN
-
Extracorporeal Shock Wave Therapy for the Treatment of Ischemic Heart Disease
NCT01241968 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effect of Nebivolol in Hypertensive Patients With Coronary Arterial Spasm
NCT03930433 ·Status: COMPLETED ·Phase: PHASE4
-
The Impact of Vericiguat on Microvascular Function in Patients with Documented Vasospastic Angina Pectoris
NCT06415227 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction
NCT05168462 ·Status: RECRUITING ·Phase: PHASE4
-
Pilot Study On The Role Of Nitric Oxide In Alpha 1-Adrenergic Vasoreactivity
NCT00240058 ·Status: COMPLETED ·Phase: NA
-
Effect of Beta Blockade on Left Ventricular Remodeling and Function in Moderate to Severe Asymptomatic Aortic Regurgitation
NCT01157572 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Isosorbide Mononitrate on Hypertension to Improve Left Ventricular Hypertrophy, Fibrosis and Myocardial Function
NCT01961453 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effects of Beta-Blocker Therapy and Phosphodiesterase Inhibition on Cardiac Neurohormonal Activation
NCT00348101 ·Status: COMPLETED ·Phase: PHASE3
-
Role of Endothelin-1 in Flow-mediated Dilatation
NCT02086253 ·Status: COMPLETED ·Phase: NA
-
NT-proBNP in Acute Dyspnea: Effects on Treatment, Hospitalisation and Costs
NCT00410293 ·Status: COMPLETED ·Phase: NA
-
The Impact of Dose of Angiotensin-receptor Blocker Valsartan and Genetic Polymorphism on the Post-MI Ventricular Remodeling
NCT01340326 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Study to Investigate Safety and Effects on Heart Rate, Blood Pressure, and Pharmacokinetic Interactions of ACT-334441
NCT02479204 ·Status: TERMINATED ·Phase: PHASE1
-
Effect of Beta-blockers on Coronary Flow and Resistance in Patients With ANOCA
NCT06864234 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of the Effect of Nebivolol to Evaluate Its Vasodilatory Effects in Hypertensive Patients
NCT00648895 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Study to Evaluate the Effect of Chronic Nitrate Therapy on Vasodilation Function in Coronary Heart Disease
NCT01430780 ·Status: UNKNOWN
-
The Effects of Inorganic Nitrate on Cardiac Muscle in Angina
NCT02078921 ·Status: COMPLETED ·Phase: PHASE2
-
Diltiazem in Jervell and Lange-Nielsen Syndrome
NCT06534671 ·Status: COMPLETED ·Phase: PHASE4
-
Physiologic Effect of Topical Nitroglycerin on Microcirculation Capacity in Patients With Circulatory Shock.
NCT05102734 ·Status: COMPLETED
-
Comparison of Nebivolol and Metoprolol With Exercise and Angiotensin II in Hypertensive Patients
NCT01502787 ·Status: COMPLETED ·Phase: PHASE4
-
Nitrite in Hypertrophic Cardiomyopathy (HCM) Study
NCT03251287 ·Status: UNKNOWN ·Phase: PHASE1
-
A Pilot Study Comparing Nebivolol and Atenolol and Its Effects With Exercise in Patients With Mild to Moderate Hypertension
NCT00200421 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Nebivolol Versus Metoprolol in Hypertensive Subject Taking Amlodipine
NCT03635125 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Left Ventricular Dysfunction During Chemotherapy
NCT01110824 ·Status: COMPLETED ·Phase: PHASE3